ADH1B and esophageal squamous cell carcinoma: The JEC study confirmed that slow‐metabolizing ADH1B was a predictor of the development of metachronous esophageal SCC after ER and inactive ALDH2 was also associated with the development of metachronous esophageal SCC.19